Staphylococcus aureus controls eicosanoid and specialized pro‐resolving mediator production via lipoteichoic acid

Staphylococcus aureus causes severe infections associated with inflammation, such as sepsis or osteomyelitis. Inflammatory processes are regulated by distinct lipid mediators (LMs) but how their biosynthetic pathways are orchestrated in S. aureus infections is elusive. We show that S. aureus strikingly not only modulates pro‐inflammatory, but also inflammation‐resolving LM pathways in murine osteomyelitis and osteoclasts as well as in human monocyte‐derived macrophages (MDMs) with different phenotype. Targeted LM metabololipidomics using ultra‐performance liquid chromatography‐tandem mass spectrometry revealed massive generation of LM with distinct LM signature profiles in acute and chronic phases of S. aureus‐induced murine osteomyelitis in vivo. In human MDM, S. aureus elevated cyclooxygenase‐2 (COX‐2) and microsomal prostaglandin E2 synthase‐1 (mPGES‐1), but impaired the levels of 15‐lipoxygenase‐1 (15‐LOX‐1), with respective changes in LM signature profiles initiated by these enzymes, that is, elevated PGE2 and impaired specialized pro‐resolving mediators, along with reduced M2‐like phenotypic macrophage markers. The cell wall component, lipoteichoic acid (LTA), mimicked the impact of S. aureus elevating COX‐2/mPGES‐1 expression via NF‐κB and p38 MAPK signalling in MDM, while the impairment of 15‐LOX‐1 correlates with reduced expression of Lamtor1. In conclusion, S. aureus dictates LM pathways via LTA resulting in a shift from anti‐inflammatory M2‐like towards pro‐inflammatory M1‐like LM signature profiles.

[1]  Soujuan Wang,et al.  Macrophage-derived LTB4 promotes abscess formation and clearance of Staphylococcus aureus skin infection in mice , 2018, PLoS pathogens.

[2]  R. Proctor,et al.  Ingestion of Staphylococcus aureus by bovine endothelial cells results in time- and inoculum-dependent damage to endothelial cell monolayers , 1987, Infection and immunity.

[3]  P. Kalinski.  Regulation of Immune Responses by Prostaglandin E2 , 2012, The Journal of Immunology.

[4]  G. Gutiérrez‐Venegas,et al.  Histamine promotes the expression of receptors TLR2 and TLR4 and amplifies sensitivity to lipopolysaccharide and lipoteichoic acid treatment in human gingival fibroblasts , 2011, Cell biology international.

[5]  D. Zeldin,et al.  Resolvin Infectious Inflammation by Targeting the Host Response. , 2015, The New England journal of medicine.

[6]  M. Fresno,et al.  Prostaglandin E2 and T cells: friends or foes? , 2011, Immunology and cell biology.

[7]  Ning Jiang,et al.  Sodium Phenylbutyrate Ameliorates Inflammatory Response Induced by Staphylococcus aureus Lipoteichoic Acid via Suppressing TLR2/NF-κB/NLRP3 Pathways in MAC-T Cells , 2018, Molecules.

[8]  R. Phipps,et al.  Prostaglandins as modulators of immunity. , 2002, Trends in immunology.

[9]  F. Mancini,et al.  Regulation of the microsomal prostaglandin E synthase‐1 in polarized mononuclear phagocytes and its constitutive expression in neutrophils , 2007, Journal of leukocyte biology.

[10]  Sun Young Park,et al.  Anti-inflammatory Effects of Curcumin in Microglial Cells , 2018, Front. Pharmacol..

[11]  Ching-Yi Cheng,et al.  Infection with Staphylococcus aureus elicits COX-2/PGE2/IL-6/MMP-9-dependent aorta inflammation via the inhibition of intracellular ROS production. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  Bo Zhu,et al.  CD200 Modulates S. aureus-Induced Innate Immune Responses Through Suppressing p38 Signaling , 2019, International journal of molecular sciences.

[13]  M. Zaiss,et al.  The double-edged role of 12/15-lipoxygenase during inflammation and immunity. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[14]  R. Medzhitov.  Origin and physiological roles of inflammation , 2008, Nature.

[15]  S. Narumiya,et al.  Opposing Immunomodulatory Roles of Prostaglandin D2 during the Progression of Skin Inflammation , 2014, The Journal of Immunology.

[16]  T. Berl,et al.  MAPK Mediation of Hypertonicity-stimulated Cyclooxygenase-2 Expression in Renal Medullary Collecting Duct Cells* , 2000, The Journal of Biological Chemistry.

[17]  C. Thiemermann,et al.  The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Serhan,et al.  The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. , 2015, Seminars in immunology.

[19]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[20]  D. Ito,et al.  Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals , 2016, Nature Communications.

[21]  R. Flavell,et al.  Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. , 2009, Current opinion in pharmacology.

[22]  S. Foster,et al.  Peptidoglycan and Lipoteichoic Acid in Gram-Positive Bacterial Sepsis: Receptors, Signal Transduction, Biological Effects, and Synergism , 2003, Shock.

[23]  T. Hartung,et al.  Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. , 2001 .

[24]  Isaac Ginsburg,et al.  Role of lipoteichoic acid in infection and inflammation. , 2002, The Lancet. Infectious diseases.

[25]  P. Bejon,et al.  The microbiology of chronic osteomyelitis: prevalence of resistance to common empirical anti-microbial regimens. , 2010, The Journal of infection.

[26]  H. Kuhn,et al.  Structural and functional biology of arachidonic acid 15-lipoxygenase-1 (ALOX15). , 2015, Gene.

[27]  D. Rosenberg,et al.  Multifaceted roles of PGE2 in inflammation and cancer , 2012, Seminars in Immunopathology.

[28]  T. Kielian,et al.  Interleukin‐10 production by myeloid‐derived suppressor cells contributes to bacterial persistence during Staphylococcus aureus orthopedic biofilm infection , 2015, Journal of leukocyte biology.

[29]  F. DeLeo,et al.  Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. , 2009, The Journal of clinical investigation.

[30]  W. Jee,et al.  The role of prostaglandins in bone in vivo. , 1990, Prostaglandins, leukotrienes, and essential fatty acids.

[31]  S. Narumiya,et al.  Anti-inflammatory role of PGD2 in acute lung inflammation and therapeutic application of its signal enhancement , 2013, Proceedings of the National Academy of Sciences.

[32]  J. Fitzpatrick,et al.  Staphylococcus aureus Infects Osteoclasts and Replicates Intracellularly , 2019, mBio.

[33]  Ajay S. Gulati,et al.  The role of cyclooxygenase-2 (COX-2) in inflammatory bone resorption. , 2007, Journal of endodontics.

[34]  S. Hauptmann,et al.  Local and systemic inflammatory mediator release in patients with acute and chronic posttraumatic osteomyelitis. , 1996, The Journal of trauma.

[35]  O. Schneewind,et al.  Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus , 2007, Proceedings of the National Academy of Sciences.

[36]  Yujie Zhou,et al.  Growth and adherence of Staphylococcus aureus were enhanced through the PGE2 produced by the activated COX-2/PGE2 pathway of infected oral epithelial cells , 2017, PloS one.

[37]  Charles N Serhan,et al.  Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. , 2018, The Journal of clinical investigation.

[38]  Vance G. Fowler,et al.  Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management , 2015, Clinical Microbiology Reviews.

[39]  S. Goerdt,et al.  Macrophage activation and polarization: nomenclature and experimental guidelines. , 2014, Immunity.

[40]  R. Harris,et al.  Role of p38 in the regulation of renal cortical cyclooxygenase-2 expression by extracellular chloride. , 2000, The Journal of clinical investigation.

[41]  D. Thuerauf,et al.  p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. , 2000, The Journal of biological chemistry.

[42]  O. Werz,et al.  Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males , 2017, The Journal of clinical investigation.

[43]  D. Steinhilber,et al.  TLR2 ligands augment cPLA2α activity and lead to enhanced leukotriene release in human monocytes , 2009, Journal of leukocyte biology.

[44]  Shun-Fa Yang,et al.  LTA and LPS mediated activation of protein kinases in the regulation of inflammatory cytokines expression in macrophages. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[45]  B. Appelmelk,et al.  Antibiotic-Induced Release of Lipoteichoic Acid and Peptidoglycan from Staphylococcus aureus: Quantitative Measurements and Biological Reactivities , 1998, Antimicrobial Agents and Chemotherapy.

[46]  C. Serhan,et al.  Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections , 2015, Nature Medicine.

[47]  Charles N. Serhan,et al.  Infection Regulates Pro-Resolving Mediators that Lower Antibiotic Requirements , 2012, Nature.

[48]  A. Gründling,et al.  Lipoteichoic acid synthesis and function in gram-positive bacteria. , 2014, Annual review of microbiology.

[49]  V. Fowler,et al.  Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms , 2019, FEMS microbiology reviews.

[50]  L. Wood,et al.  Dietary Fatty Acids Amplify Inflammatory Responses to Infection through p38 MAPK Signaling , 2019, American journal of respiratory cell and molecular biology.

[51]  C. Bachert,et al.  Staphylococcus aureus enterotoxin B regulates prostaglandin E2 synthesis, growth, and migration in nasal tissue fibroblasts. , 2008, The Journal of infectious diseases.

[52]  Charles N. Serhan,et al.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[53]  L. Neckers,et al.  IL‐1β mediated up‐regulation of HIF‐lα via an NFkB/COX‐2 pathway identifies HIF‐1 as a critical link between inflammation and oncogenesis , 2003 .

[54]  M. Rohde,et al.  A novel mouse model of Staphylococcus aureus chronic osteomyelitis that closely mimics the human infection: an integrated view of disease pathogenesis. , 2012, The American journal of pathology.

[55]  S. Kaesler,et al.  Induction of IL‐10‐balanced immune profiles following exposure to LTA from Staphylococcus epidermidis , 2018, Experimental dermatology.

[56]  J. S. Goodman,et al.  Lysostaphin: an enzymatic approach to staphylococcal disease. 3. Combined lysostaphin-methicillin therapy of established staphylococcal abscesses in mice. , 1968, The Yale journal of biology and medicine.

[57]  R. Guldberg,et al.  COX-2 from the injury milieu is critical for the initiation of periosteal progenitor cell mediated bone healing. , 2008, Bone.

[58]  Y. Urade,et al.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. , 2011, Chemical reviews.

[59]  S. Mattingly,et al.  Comparative analysis of the localization of lipoteichoic acid in Streptococcus agalactiae and Streptococcus pyogenes , 1987, Infection and immunity.

[60]  Timothy Foster,et al.  A Potential New Pathway for Staphylococcus aureus Dissemination: The Silent Survival of S. aureus Phagocytosed by Human Monocyte-Derived Macrophages , 2008, PloS one.

[61]  Chien-Huang Lin,et al.  Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-kappaB pathways. , 2006, Cellular signalling.

[62]  D. Aronoff,et al.  Prostaglandin E2 Inhibits Alveolar Macrophage Phagocytosis through an E-Prostanoid 2 Receptor-Mediated Increase in Intracellular Cyclic AMP12 , 2004, The Journal of Immunology.

[63]  I. Marriott,et al.  Staphylococcus aureus Induces Expression of Receptor Activator of NF-κB Ligand and Prostaglandin E2 in Infected Murine Osteoblasts , 2008, Infection and Immunity.

[64]  O. Werz,et al.  Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity , 2018, Nature Communications.

[65]  M. Otto.  Staphylococcus colonization of the skin and antimicrobial peptides. , 2010, Expert review of dermatology.

[66]  M. Perretti,et al.  Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis , 2009, Nature.

[67]  J. Wallace,et al.  Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[68]  K. Ko,et al.  Alternative Enzyme Protection Assay To Overcome the Drawbacks of the Gentamicin Protection Assay for Measuring Entry and Intracellular Survival of Staphylococci , 2019, Infection and Immunity.

[69]  O. Werz,et al.  Vacuolar (H+)-ATPase Critically Regulates Specialized Proresolving Mediator Pathways in Human M2-like Monocyte-Derived Macrophages and Has a Crucial Role in Resolution of Inflammation , 2019, The Journal of Immunology.

[70]  L. Webb,et al.  Intracellular Staphylococcus aureus and antibiotic resistance: Implications for treatment of staphylococcal osteomyelitis , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[71]  Changwei Qiu,et al.  Polydatin reduces Staphylococcus aureus lipoteichoic acid‐induced injury by attenuating reactive oxygen species generation and TLR2‐NFκB signalling , 2017, Journal of cellular and molecular medicine.

[72]  W. Schaffner,et al.  Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies. , 1967, The Yale journal of biology and medicine.

[73]  F. Lowy,et al.  Staphylococcus aureus infections: transmission within households and the community. , 2015, Trends in microbiology.

[74]  O. Werz,et al.  Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[76]  S. Gangloff,et al.  Staphylococcus aureus vs. Osteoblast: Relationship and Consequences in Osteomyelitis , 2015, Front. Cell. Infect. Microbiol..

[77]  F. Uhle,et al.  From macrophage to osteoclast – How metabolism determines function and activity , 2018, Cytokine.

[78]  O. Werz,et al.  Staphylococcus aureus-Derived α-Hemolysin Evokes Generation of Specialized Pro-resolving Mediators Promoting Inflammation Resolution , 2020, Cell reports.

[79]  M. Rothe,et al.  Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2* , 1999, The Journal of Biological Chemistry.